Trademark: 78397614
Status Date
Wednesday, March 28, 2007
Filing Date
Wednesday, April 7, 2004
Published for Opposition
Tuesday, January 18, 2005
Abandoned Date
Wednesday, March 28, 2007
5 use as a housemark for Vaccines, therapeutic vaccines and therapeutic pharmaceuticals derived from monoclonal antibodies for use in the treatment of cancer, autoimmune disorders, infectious diseases and graft-verus-host disease
Jun 1, 2007
Abandonment Notice Mailed - No Use Statement Filed
Jun 1, 2007
Abandonment - No Use Statement Filed
Sep 26, 2006
Extension 2 Granted
Sep 26, 2006
Extension 2 Filed
Sep 26, 2006
Teas Extension Received
Apr 10, 2006
Extension 1 Granted
Mar 27, 2006
Extension 1 Filed
Mar 28, 2006
Extension Received With Teas Petition
Mar 28, 2006
Petition To Revive-Granted
Mar 28, 2006
Teas Petition To Revive Received
Sep 27, 2005
Noa Mailed - Sou Required From Applicant
Aug 17, 2005
Extension Of Time To Oppose Process - Terminated
Jul 22, 2005
Amendment From Applicant Entered
Jul 15, 2005
Correspondence Received In Law Office
Jul 15, 2005
Fax Received
Jul 15, 2005
Fax Received
Feb 2, 2005
Extension Of Time To Oppose Received
Jan 18, 2005
Published For Opposition
Dec 29, 2004
Notice Of Publication
Nov 18, 2004
Law Office Publication Review Completed
Nov 18, 2004
Assigned To Lie
Nov 15, 2004
Teas Voluntary Amendment Received
Oct 29, 2004
Approved For Pub - Principal Register
Oct 29, 2004
Assigned To Examiner
Apr 15, 2004
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
